SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
The most pressing issues of the secondary drug prevention of the most common cardiovascular diseases are focused. These are arterial hypertension, stable ischemic heart disease, chronicheart failure.
Saved in:
Main Authors: | E. V. Filippov (Author), S. S. Yakushin (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
by: E. V. Filippov, et al.
Published: (2015) -
Non-pharmacological secondary prevention of cardiovascular diseases in patients with stable angina at specialized ambulatory institution
by: S. B. Fitilev, et al.
Published: (2018) -
EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE
by: G. De Backer, et al.
Published: (2015) -
EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE
by: G. De Backer, et al.
Published: (2015) -
SUDDEN CARDIAC DEATH: PROBLEM OF RISK STRATIFICATION AND CHOICE OF THERAPY
by: E. V. Filippov, et al.
Published: (2016)